You are currently viewing a new version of our website. To view the old version click .
  • Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Hematology Reports, Volume 4, Issue 3

July 2012 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
13 Citations
4 Pages

Overexpression of Lung Resistance-Related Protein and P-Glycoprotein and Response to Induction Chemotherapy in Acute Myelogenous Leukemia

  • Kazue Tsuji,
  • Yan-Hua Wang,
  • Minoko Takanashi,
  • Tsuyoshi Odajima,
  • Gabriel A. Lee,
  • Hiroki Sugimori and
  • Toshiko Motoji

1 October 2012

Lung resistance-related protein (LRP) and P-glycoprotein (P-gp) are associated with multidrug resistance. P-gp overexpression reduces intracellular anticancer drug concentrations and is correlated with low remission rates. However, whether the presen...

  • Article
  • Open Access
10 Citations
6 Pages

28 September 2012

More than 50% of myeloma cases have normal karyotypes under conventional cytogenetic analysis due to low mitotic activity and content of plasma cells in the bone marrow. We used a polymerase chain reaction (PCR)-based translocation detection assay to...

  • Case Report
  • Open Access
4 Citations
3 Pages

Pure Red Cell Aplasia in a Simultaneous Pancreas-Kidney Transplantation Patient: Inside the Erythroblast

  • Francesca Labbadia,
  • Eduardo Salido-Fierréz,
  • Juliana Majado-Martinez,
  • Valentin Cabañas-Perianes and
  • José M. Moraleda Jiménez

10 September 2012

A case of pure red cell aplasia in a simultaneous kidney-pancreas transplant recipient on immunosuppressive therapy is reported here. The patient presented with anemia unresponsive to erythropoietin treatment. Bone marrow cytomorphology was highly su...

  • Case Report
  • Open Access
8 Citations
5 Pages

B-Cell Acute Lymphoblastic Leukemia with t(4;11)(q21;q23) in a Young Woman: Evolution into Mixed Phenotype Acute Leukemia with Additional Chromosomal Aberrations in the Course of Therapy

  • Giovanni Carulli,
  • Alessandra Marini,
  • Maria I. Ferreri,
  • Antonio Azzarà,
  • Virginia Ottaviano,
  • Tiziana Lari,
  • Melania Rocco,
  • Stefano Giuntini and
  • Mario Petrini

6 September 2012

About 5% of adult B-cell acute lymphoblastic leukemias (B-ALL) are characterized by t(4;11)(q21;q23), which confers peculiar features to this B-ALL subtype, including a very immature immunophenotype and poor prognosis. We describe the case of a 21-ye...

  • Case Report
  • Open Access
5 Citations
4 Pages

Epstein-Barr Virus-Negative Aggressive Natural Killer-Cell Leukaemia with High P-Glycoprotein Activity and Phosphorylated Extracellular Signal-Regulated Protein Kinases 1 and 2

  • Sanja Perkovic,
  • Sandra Basic-Kinda,
  • Vladimir Gasparovic,
  • Zeljko Krznaric,
  • Jaksa Babel,
  • Ivana Ilic,
  • Igor Aurer and
  • Drago Batinic

4 September 2012

Aggressive natural killer-cell leukaemia (ANKL) is a rare type of disease with fulminant course and poor outcome. The disease is more prevalent among Asians than in other ethnic groups and shows strong association with Epstein-Barr virus (EBV) and P-...

  • Article
  • Open Access
2 Citations
5 Pages

Combination of Cyclophosphamide, Etoposide, Carboplatin and Dexamethasone as a Salvage Regimen for Refractory Multiple Myeloma Patients: A Comparison with a Historical Control Group

  • Reza Safaee,
  • Ahmad Ahmadzadeh,
  • Ramezanali Sharifian,
  • Amirhossein Emami,
  • Mir Saeed Yekaninejad,
  • Mohammad Hossein Jalili and
  • Armita Valizadeh

The aim of this study was to design a regimen for refractory multiple myeloma with minimum complications to achieve a reasonable response. Fifteen patients with active multiple myeloma after at least two lines of conventional treatment underwent ther...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hematol. Rep. - ISSN 2038-8330